Results 131 to 140 of about 401,465 (309)

Targeting CDK6 and BCL2 Exploits the MYB Addiction of Ph+ Acute Lymphoblastic Leukemia [PDF]

open access: yes, 2018
Philadelphia chromosome–positive acute lymphoblastic leukemia (Phþ ALL) is currently treated with BCR-ABL1 tyrosine kinase inhibitors (TKI) in combination with chemotherapy. However, most patients develop resistance to TKI through BCR-ABL1–dependent and –
Addya, Sankar   +12 more
core   +1 more source

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.

open access: yesBlood, 2018
As a consequence of acquired or intrinsic disease resistance, the prognosis for patients with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) is dismal. Novel, less toxic drugs are clearly needed.
Karen L. Bride   +21 more
semanticscholar   +1 more source

Breastfeeding patterns and risk of childhood acute lymphoblastic leukaemia. [PDF]

open access: yes, 2005
The risk of childhood acute lymphoblastic leukaemia (ALL) was investigated in relation to breastfeeding patterns in the Northern California Childhood Leukaemia Study.
Block, G   +6 more
core   +2 more sources

Model-based simulation of maintenance therapy of childhood acute lymphoblastic leukemia [PDF]

open access: yesarXiv, 2019
Acute lymphoblastic leukemia is the most common malignancy in childhood. Successful treatment requires initial high-intensity chemotherapy, followed by low-intensity oral maintenance therapy with oral 6-mercaptopurine (6MP) and methotrexate (MTX) until 2-3 years after disease onset.
arxiv  

Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia. [PDF]

open access: yes, 2016
High hyperdiploidy (HD), the most common cytogenetic subtype of B-cell acute lymphoblastic leukemia (B-ALL), is largely curable but significant treatment-related morbidity warrants investigating the biology and identifying novel drug targets.
de Smith, Adam J   +10 more
core   +1 more source

Genetic Basis of Acute Lymphoblastic Leukemia.

open access: yesJournal of Clinical Oncology, 2017
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and despite cure rates exceeding 90% in children, it remains an important cause of morbidity and mortality in children and adults.
I. Iacobucci, C. Mullighan
semanticscholar   +1 more source

Reply: Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect [PDF]

open access: yes, 2017
No abstract ...
Baird, Susan F.   +5 more
core   +1 more source

Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia

open access: yesHaematologica, 2015
In contrast to acute lymphoblastic leukemia in children, adult cases of this disease are associated with a very poor prognosis. In order to ascertain whether the frequencies and patterns of submicroscopic changes, identifiable with single nucleotide ...
Setareh Safavi   +5 more
doaj   +1 more source

Automated Immunophenotyping Assessment for Diagnosing Childhood Acute Leukemia using Set-Transformers [PDF]

open access: yesarXiv
Acute Leukemia is the most common hematologic malignancy in children and adolescents. A key methodology in the diagnostic evaluation of this malignancy is immunophenotyping based on Multiparameter Flow Cytometry (FCM). However, this approach is manual, and thus time-consuming and subjective. To alleviate this situation, we propose in this paper the FCM-
arxiv  

Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.

open access: yesBlood, 2017
Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia (ALL) is a high-risk subtype of ALL in children. There are conflicting data on the incidence and prognosis of Ph-like ALL in adults.
N. Jain   +27 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy